Sign in
WithdrawnNo phase

Managing Colorectal Cancer Prevention Procedure Wait Lists During the COVID-19 Pandemic

Key facts

Who runs it
Centre hospitalier de l'Université de Montréal (CHUM)
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Withdrawn
Started
Jun 2022
Ended
Dec 2023
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • colonoscopy
  • FIT test
  • CT colonography
Record updated
29 November 2022
Why it stopped
The study was never started due to lack of staff

Who can take part

Age
45 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • people with referral sheets for surveillance colonoscopies : meaning 3 or 5 years after the initial colonoscopy

Who cannot take part

  • Crohn's disease
  • familial polyposis syndrome
  • patients with a personal history of CRC
  • patients diagnosed with a CRC or a metastatic cancer
  • patients with a history of contrast allergies
  • known or suspected acute diverticulitis
  • ulcerative colitis
  • toxic megacolon
  • acute abdominal pain
  • coagulopathy
  • poor general health (defined as an American Society of Anaesthesiologists class >3)
  • patients presenting for emergency colonoscopies
  • patients incapable of lying flat on their back for the duration of the CT colonography due CHF or other predispositions
  • patient undergoing colonoscopy for surveillance after EMR or ESD procedures
  • Patients referred for polypectomy

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The main objective of this study is to offer and evaluate an interim triage approach for patients waiting for surveillance colonoscopies. This will reduce the waiting period and the psychological stressors for our patients and from a scientific point of view allow us to compare the yield of findings for each approach.

The 3 groups in the trial

  • a colonoscopy as surveillance examExisting treatment, for comparison

    patients will undergo Colonoscopy, finding will be documented. Findings of colonoscopy will be documented and treated according to the institutional standards. Study participation for patients ends after the colonoscopy and follow-up of pathology results and complication assessment.

    Treatment: colonoscopy

  • undergoing a FIT as surveillance examExisting treatment, for comparison

    if the FIT test is positive: patients will have subsequent colonoscopy within 3 months. Findings of FIT testing and if positive the colonoscopy will be documented and participation in the study will end after that. Findings of the FIT test and colonoscopy will be treated according to the institutional standards. If FIT test is negative patient will leave the study and will have a follow up with a colonoscopy or FIT test in 1 to 2 years outside of this study.

    Treatment: FIT test

  • undergoing CT colonography as surveillance examExisting treatment, for comparison

    If CTC is positive: patients will have subsequent colonoscopy within 3 months. Findings will be documented and participation in the study will end there. Findings of the colonoscopy will be addressed according to our institution's guidelines. If CTC is negative for polypoid lesions patient will leave the study and will have a follow up 5 years after with either a CTC or colonoscopy.

    Treatment: CT colonography

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
29 November 2022